Sanofi lowers Lantus insulin costs by 78% in U.S. market
Sanofi, a French pharmaceutical major, announced it would slash the price of insulin, Lantus, by 78% for all U.S. patients with commercial insurance.
Drugs
Medical
Pharma
Drugs
Medical
Pharma
FDA nod for Pfizer-Biotech vaccine booster for children
The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four.
Drugs
Pharma
Novo Nordisk follows Eli Lilly on insulin price cuts
Denmark's Novo Nordisk plans to effect a 75% cut in insulin prices in the U.S. market by January 1, 2024.
Drugs
Health
Medical
Don’t play “geopolitical football” with COVID-19 virus origins: WHO
The WHO urged nations to come forward with information regarding the origins of the COVID-19 virus and not play "geopolitical football" as it.
Drugs
Pharma
FDA rejects Cytokinetics heart disease trial drug
Cytokinetics, a US-based biopharmaceutical company, announced the FDA had rejected its new drug application for approving a trial drug to treat heart problems.
Drugs
Pharma
Redx, Jounce to merge in a $425 million all-share deal
Redx Pharma, based in the UK and Jounce Therapeutics, US, will merge in an all-share transaction worth $425 million to establish a new.
Drugs
Medical
Pharma
Merck’s pill fails to prevent COVID-19 infection among households
Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.
Drugs
Pharma
Glenmark gets 2nd FDA nod for high blood sugar drug
Glenmark Pharmaceuticals, a US-based company, has received a tentative second FDA approval for its oral drug to treat high blood pressure.
Health
Medical
Pharma
U.S. to end Covid-19 curbs on May 11, migrant policy remains same
The U.S. plans to end COVID-19 emergency restrictions by May 11, according to a statement by the Office of Management and Budget.